<?xml version="1.0" encoding="UTF-8"?>
<ref id="B10">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Currie</surname>
    <given-names>S. M.</given-names>
   </name>
   <name>
    <surname>Findlay</surname>
    <given-names>E. G.</given-names>
   </name>
   <name>
    <surname>McFarlane</surname>
    <given-names>A. J.</given-names>
   </name>
   <name>
    <surname>Fitch</surname>
    <given-names>P. M.</given-names>
   </name>
   <name>
    <surname>Böttcher</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Colegrave</surname>
    <given-names>N.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2016</year>). 
  <article-title>Cathelicidins have direct antiviral activity against respiratory syncytial virus in vitro and protective function in vivo in mice and humans.</article-title>
  <source>
   <italic>J. Immunol.</italic>
  </source>
  <volume>196</volume>
  <fpage>2699</fpage>–
  <lpage>2710</lpage>. 
  <pub-id pub-id-type="doi">10.4049/jimmunol.1502478</pub-id>
  <?supplied-pmid 26873992?>
  <pub-id pub-id-type="pmid">26873992</pub-id>
 </mixed-citation>
</ref>
